Global Drug Facility
E26394
The Global Drug Facility is an international initiative that improves worldwide access to quality-assured tuberculosis medicines and diagnostics, particularly in low- and middle-income countries.
Statements (48)
| Predicate | Object |
|---|---|
| instanceOf |
global procurement mechanism
→
international health initiative → tuberculosis control program → |
| aimsTo |
improve access to quality-assured tuberculosis diagnostics
→
improve access to quality-assured tuberculosis medicines → |
| benefits |
non-governmental tuberculosis providers
→
public sector tuberculosis programs → |
| collaboratesWith |
Global Fund to Fight AIDS, Tuberculosis and Malaria
→
UN agencies → World Health Organization → |
| contributesTo |
global tuberculosis control
→
universal access to tuberculosis care → |
| ensures |
international quality standards for tuberculosis medicines
→
quality-assured tuberculosis medicines → |
| focusesOnDisease |
tuberculosis
→
|
| foundedFor |
expanding access to high-quality tuberculosis drugs at low cost
→
|
| hasAbbreviation |
GDF
→
|
| headquarteredIn |
Geneva
→
|
| headquarteredInCountry |
Switzerland
→
|
| languageOfWork |
English
→
|
| monitors |
product quality and supply performance
→
|
| objective |
improve forecasting and supply planning for tuberculosis commodities
→
reduce stock-outs of tuberculosis medicines → |
| operatedBy |
Stop TB Partnership
→
|
| promotes |
use of WHO-prequalified products
→
|
| provides |
first-line tuberculosis medicines
→
pediatric tuberculosis formulations → procurement services → second-line tuberculosis medicines → supply chain services → tuberculosis diagnostic products → |
| sector |
global health
→
pharmaceutical procurement → |
| servesCountries |
low-income countries
→
middle-income countries → |
| supports |
affordable pricing for tuberculosis commodities
→
drug-resistant tuberculosis treatment scale-up → implementation of WHO tuberculosis treatment guidelines → introduction of new tuberculosis medicines and regimens → |
| targetPopulation |
people with drug-resistant tuberculosis
→
people with tuberculosis → |
| uses |
long-term agreements with manufacturers
→
pooled procurement → |
| worksOn |
market shaping for tuberculosis medicines and diagnostics
→
|
| worksWith |
international donors
→
ministries of health → national tuberculosis programs → technical partners → |
Referenced by (1)
| Subject (surface form when different) | Predicate |
|---|---|
|
Stop TB Partnership
→
|
program |